Sharekhan

Alpa Laboratories Ltd

Wed 21/05/2025,15:51:10 | NSE : ALPA

₹ 107.01-0.21 (-0.20%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 105.46

Previous Close

₹ 107.22

Volume

8248

Mkt Cap ( Rs. Cr)

₹225.16

High

₹ 108.40

Low

₹ 105.46

52 Week High

₹ 144.50

52 Week Low

₹ 69.90

Book Value Per Share

₹ 78.24

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Alpa Laboratories Ltd

Your Vote -

Buy

68.75%

Hold

12.50%

Sell

18.75%

68.75%

32 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Alpa Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Alpa Laboratories Lt has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    16 Apr 2025, 5:41PM As of March 2025, 57.29% is owned by Indian Promoters and 42.71% by Public. <p align=justify> Top five Promoters holding highest number of shares of A
  • Alpa Laboratories Lt - Trading Window

    28 Mar 2025, 10:59AM Alpa Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations
  • Alpa Laboratories Lt - Trading Window-XBRL

    26 Mar 2025, 5:05PM ALPA LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window
  • Alpa Laboratories Lt - Reply to Clarification- Financial results

    19 Mar 2025, 10:20AM The Exchange had sought clarification from Alpa Laboratories Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (List
  • Alpa Laboratories Lt - Clarification On The Format Prescribed By SEBI For The Financial Results.

    18 Mar 2025, 4:50PM Clarification on the format prescribed by SEBI for the Financial Results.
  • Alpa Laboratories Lt - Clarification - Financial Results

    6 Mar 2025, 8:17PM The Exchange has sought clarification from Alpa Laboratories Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (List

Key fundamentals

Evaluate the intrinsic value of Alpa Laboratories Ltd stock 

Name March-24 March-23 March-22 March-21 March-20
Assets 167.2191 147.1215 137.4871 117.5297 110.4216
Liabilities 167.2191 147.1215 137.4871 117.5297 110.4216
Equity 21.0406 21.0406 21.0406 21.0406 21.0406
Gross Profit 8.1447 8.0761 10.6864 7.7085 3.452
Net Profit 16.7777 12.6243 14.1258 7.2644 4.0781
Cash From Operating Activities 3.6991 8.8196 2.2041 -1.4511 17.6568
NPM(%) 15.42 13.58 12.58 7.44 4.74
Revenue 108.7391 92.9552 112.2664 97.554 85.9691
Expenses 100.5944 84.8791 101.58 89.8455 82.5171
ROE(%) 10.19 7.66 8.58 4.41 2.47

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Alpa Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 810.15 -0.84 26.88 61.21 301.39 0.62
Lotus Eye Hospital and Institute Ltd 74.06 0.78 308.58 223.04 14.01 0.68
Vaishali Pharma Ltd 12.85 -1.15 428.33 114.96 2.76 0.00
Astec Lifesciences Ltd 701.25 -1.59 0.00 210.31 -687.11 0.00

Company Info

Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, partners of M/s Alpa Laboratories, which was formed in the year 1967, incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In the year 1998, Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited". In the year 1997, we initiated setting of a new manufacturing unit at 33/2, Pigdamber, A.B. Road, Rau, District Indore, Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. We manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark "Alpa" which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. We also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, we also undertake contract manufacturing of a large variety of pharmaceuticals. We manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. We have an established product-marketing network covering both metro and mini metro cities, which enable us to reach our existing and potential customers through our network of distributors and dealers spread across the country. For the purpose of marketing the various products, our Company's business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. HISTORY AND MAJOR EVENTS 1988 Incorporation of Alpa Laboratories Private Limited 1997 Commenced setting up of manufacturing facility at Pigdamber, Indore 1998 Conversion to Alpa Laboratories Limited, a public limited company 1999 Start of commercial production 2001 WHO GMP Certification for its manufacturing facilities Entered into an agreement for Contract manufacturing at its newly constructed facility, with Plethico Pharmaceuticals Ltd., a Pharmaceutical company, for manufacturing its various range of products. The manufacturing facilities at Pigdamber were certified as WHO GMP compliant by SGS-ICS Belgium for the period 2001-02. 2003 Certified ISO 9001: 2000* The manufacturing facility at Pigdamber was approved by the Director General of Quality Assurance (DGQA), India thereby opening its doors for participating in Tenders for supplies to defence institutions** Started export of its Veterinary products and registered its 7 veterinary products in Sudan 2006 Started participation in international tenders for export in addition to domestic marketing abroad and won a major tender from CMS, Sudan. Launched Veterinary Division with a new face and ethical promotion of its Veterinary products launched in 5 states in the year 2006. Launched Ethical division for its human products * Expired on May 14, 2006 ** Expired on January 22, 2006. This certificate is not required now as our revenue have crossed Rs 2000.00 lakhs as per DGQA norms. 2007 -Alpa Laboratories ties up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products. 2010 - The Company has recommended dividend of 10%. 2014 - Ms. Monali Patel, Member of The Institute of Company Secretaries of India (ICSI) has been appointed as the Company Secretary and Compliance Officer. - Alpa Laboratories has sold its Unit-II ("Undertaking) situated at Sector III, Pithampur, Dhar (M.P.) as a going concern on a slump sale basis to Ipca Laboratories Limited. 2015 -Alpa Laboratories Ltd has formed a wholly owned subsidiary under the name and style of Norfolk Mercantile Private Ltd.

Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, partners of M/s Alpa Laboratories, which was formed in the year 1967, incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In the year 1998, Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3, 1998 with the name of "Alpa Laboratories Limited". In the year 1997, we initiated setting of a new manufacturing unit at 33/2, Pigdamber, A.B. Road, Rau, District Indore, Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams. We manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark "Alpa" which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. We also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, we also undertake contract manufacturing of a large variety of pharmaceuticals. We manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. We have an established product-marketing network covering both metro and mini metro cities, which enable us to reach our existing and potential customers through our network of distributors and dealers spread across the country. For the purpose of marketing the various products, our Company's business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division. HISTORY AND MAJOR EVENTS 1988 Incorporation of Alpa Laboratories Private Limited 1997 Commenced setting up of manufacturing facility at Pigdamber, Indore 1998 Conversion to Alpa Laboratories Limited, a public limited company 1999 Start of commercial production 2001 WHO GMP Certification for its manufacturing facilities Entered into an agreement for Contract manufacturing at its newly constructed facility, with Plethico Pharmaceuticals Ltd., a Pharmaceutical company, for manufacturing its various range of products. The manufacturing facilities at Pigdamber were certified as WHO GMP compliant by SGS-ICS Belgium for the period 2001-02. 2003 Certified ISO 9001: 2000* The manufacturing facility at Pigdamber was approved by the Director General of Quality Assurance (DGQA), India thereby opening its doors for participating in Tenders for supplies to defence institutions** Started export of its Veterinary products and registered its 7 veterinary products in Sudan 2006 Started participation in international tenders for export in addition to domestic marketing abroad and won a major tender from CMS, Sudan. Launched Veterinary Division with a new face and ethical promotion of its Veterinary products launched in 5 states in the year 2006. Launched Ethical division for its human products * Expired on May 14, 2006 ** Expired on January 22, 2006. This certificate is not required now as our revenue have crossed Rs 2000.00 lakhs as per DGQA norms. 2007 -Alpa Laboratories ties up with Vhermann Pharmaceutical Inc, Philippines for distribution of its products. 2010 - The Company has recommended dividend of 10%. 2014 - Ms. Monali Patel, Member of The Institute of Company Secretaries of India (ICSI) has been appointed as the Company Secretary and Compliance Officer. - Alpa Laboratories has sold its Unit-II ("Undertaking) situated at Sector III, Pithampur, Dhar (M.P.) as a going concern on a slump sale basis to Ipca Laboratories Limited. 2015 -Alpa Laboratories Ltd has formed a wholly owned subsidiary under the name and style of Norfolk Mercantile Private Ltd.

Read More

Parent Organisation

Alpa Laboratories Ltd.

Founded

18/03/1988

Managing Director

Mr.Paresh Chawla

NSE Symbol

ALPAEQ

FAQ

The current price of Alpa Laboratories Ltd is ₹ 107.01.

The 52-week high for Alpa Laboratories Ltd is ₹ 108.40 and the 52-week low is ₹ 105.46.

The market capitalization of Alpa Laboratories Ltd is currently ₹ 225.16. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Alpa Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Alpa Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Alpa Laboratories Ltd shares.

The CEO of Alpa Laboratories Ltd is Mr.Paresh Chawla, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT